Exploring 3 Undervalued Small Caps In Global With Insider Activity

In recent weeks, global markets have shown resilience, with U.S. small-cap indexes advancing for the fourth consecutive week amid easing trade tensions and better-than-expected earnings reports. Despite a mixed economic backdrop with contracting GDP and cooling job openings, investor sentiment remains buoyant, particularly in the small-cap space where growth potential often intersects with market optimism. In this environment, identifying promising small-cap stocks involves looking for companies that demonstrate robust fundamentals and strategic insider activity—signals that can indicate confidence in their future prospects even amidst broader economic uncertainties.

Top 10 Undervalued Small Caps With Insider Buying Globally

Name	PE	PS	Discount to Fair Value	Value Rating
Tristel	28.4x	4.0x	24.32%	★★★★★★
Propel Holdings	17.7x	1.8x	34.76%	★★★★★☆
Nexus Industrial REIT	5.3x	2.7x	24.07%	★★★★★☆
Chorus Aviation	NA	0.4x	16.36%	★★★★★☆
Savaria	26.2x	1.5x	42.48%	★★★★☆☆
Savills	24.5x	0.5x	42.10%	★★★★☆☆
Sing Investments & Finance	7.0x	3.6x	44.05%	★★★★☆☆
FRP Advisory Group	12.8x	2.3x	13.47%	★★★☆☆☆
Italmobiliare	11.4x	1.5x	-275.29%	★★★☆☆☆
Arendals Fossekompani	NA	1.6x	42.97%	★★★☆☆☆

Click here to see the full list of 156 stocks from our Undervalued Global Small Caps With Insider Buying screener.

We're going to check out a few of the best picks from our screener tool.

Integral Diagnostics (ASX:IDX)

Simply Wall St Value Rating: ★★★☆☆☆

Overview: Integral Diagnostics operates diagnostic imaging facilities, providing medical imaging services across Australia and New Zealand, with a market cap of approximately A$1.06 billion.

Operations: Integral Diagnostics generates revenue primarily from its diagnostic imaging facilities, with a recent revenue figure of A$491.32 million. The company's gross profit margin shows a downward trend, reaching 31.66% as of the latest period. Operating expenses, including general and administrative costs, are significant components impacting net income margins, which have been volatile recently.

PE: 157.1x

Integral Diagnostics, a diagnostic imaging company, has recently caught the eye of private equity firms after its market value dipped to A$837 million following half-year results. Despite reporting a net loss of A$0.396 million for the period ending December 2024, insider confidence is evident with James Hall purchasing 36,000 shares valued at approximately A$78,840 between February and March 2025. The company's earnings are anticipated to grow by over 40% annually, suggesting potential for future growth in the healthcare sector.

• Dive into the specifics of Integral Diagnostics here with our thorough valuation report.

• Gain insights into Integral Diagnostics' historical performance by reviewing our past performance report.

Region Group (ASX:RGN)

Simply Wall St Value Rating: ★★★☆☆☆

Overview: Region Group operates as a real estate investment trust focusing on commercial properties, with a market cap of A$3.45 billion.

Operations: Region Group generates revenue primarily from its commercial real estate investments, with recent figures showing a gross profit margin of 61.91%. The company has experienced fluctuations in net income margins, ranging from positive to negative values over recent periods. Operating expenses and non-operating expenses have had significant impacts on net income outcomes.

PE: 20.2x

Region Group's recent insider confidence is evident, with Steven Crane acquiring 100,000 shares, reflecting a 33% increase in their holdings. The company announced a A$100 million share repurchase program on April 3, 2025, leveraging proceeds from a A$76 million property sale. Financially, Region Group reported an impressive turnaround with A$81.8 million net income for H1 2025 compared to the previous year's loss. Despite relying on external borrowing for funding, earnings are projected to grow annually by 12.4%.

• Unlock comprehensive insights into our analysis of Region Group stock in this valuation report.

• Understand Region Group's track record by examining our Past report.

Badger Infrastructure Solutions (TSX:BDGI)

Simply Wall St Value Rating: ★★★★★★

Overview: Badger Infrastructure Solutions specializes in non-destructive excavation services, primarily through its fleet of hydrovac trucks, and has a market capitalization of approximately $1.16 billion CAD.

Operations: Badger Infrastructure Solutions generates revenue primarily from its operations, with a recent figure of $756.02 million. The company has seen fluctuations in its net income margin, which reached 6.53% recently, while the gross profit margin was at 29.37%. Cost of goods sold and operating expenses are significant components impacting overall profitability.

PE: 20.2x

Badger Infrastructure Solutions, a smaller company in the infrastructure sector, displays signs of being undervalued with recent earnings growth. For Q1 2025, sales rose to US$172.63 million from US$161.56 million last year, while net income nearly doubled to US$3.26 million. Insider confidence is evident as insiders have been purchasing shares recently. The company has also repurchased 424,500 shares for CAD 15.89 million from October 2024 to March 2025, suggesting management's belief in its potential value increase despite high debt levels and reliance on external borrowing for funding.

• Navigate through the intricacies of Badger Infrastructure Solutions with our comprehensive valuation report here.

• Assess Badger Infrastructure Solutions' past performance with our detailed historical performance reports.

Summing It All Up

• Get an in-depth perspective on all 156 Undervalued Global Small Caps With Insider Buying by using our screener here.
• Got skin in the game with these stocks? Elevate how you manage them by using Simply Wall St's portfolio, where intuitive tools await to help optimize your investment outcomes.
• Discover a world of investment opportunities with Simply Wall St's free app and access unparalleled stock analysis across all markets.

Interested In Other Possibilities?

• Explore high-performing small cap companies that haven't yet garnered significant analyst attention.
• Fuel your portfolio with companies showing strong growth potential, backed by optimistic outlooks both from analysts and management.
• Find companies with promising cash flow potential yet trading below their fair value.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com